Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2016

Conditions
Prostate Cancer
Interventions
RADIATION

Radiotherapy

3D-CRT or IMRT 64.8-70.2 Gy to the prostatic fossa begins 12 weeks (+/- 1 week) after Samarium 153 administration. Daily tumor doses of 1.8 - 2.0 Gy per day, 5 days per week x 7-8 weeks.

DRUG

Samarium 153

Samarium 153 lexidronam dose 2.0 mCi/kg by IV injection one time within 2 weeks (+/- 3days) after registration.

Trial Locations (29)

19713

CCOP - Christiana Care Health Services, Newark

23454

Coastal Cancer Center at Sentara Virginia Beach General Hospital, Virginia Beach

23507

Sentara Cancer Institute at Sentara Norfolk General Hospital, Norfolk

31904

John B. Amos Cancer Center, Columbus

39581

Regional Cancer Center at Singing River Hospital, Pascagoula

44203

Barberton Citizens Hospital, Barberton

44266

Robinson Radiation Oncology, Ravenna

44307

McDowell Cancer Center at Akron General Medical Center, Akron

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

63141

David C. Pratt Cancer Center at St. John's Mercy, St Louis

73104

Oklahoma University Cancer Institute, Oklahoma City

85013

Arizona Oncology Services Foundation, Phoenix

90027

Kaiser Permanente Medical Center - Los Angeles, Los Angeles

95603

Auburn Radiation Oncology, Auburn

95608

Mercy Cancer Center at Mercy San Juan Medical Center, Carmichael

95661

Radiation Oncology Center - Roseville, Roseville

95682

Radiation Oncology Centers - Cameron Park, Cameron Park

95687

Solano Radiation Oncology Center, Vacaville

95815

Radiological Associates of Sacramento Medical Group, Incorporated, Sacramento

95817

University of California Davis Cancer Center, Sacramento

95819

Mercy General Hospital, Sacramento

32610-0232

University of Florida Shands Cancer Center, Gainesville

71315-3198

Tulane Cancer Center Office of Clinical Research, Alexandria

02721

Hudner Oncology Center at Saint Anne's Hospital - Fall River, Fall River

49007-3731

West Michigan Cancer Center, Kalamazoo

59107-7000

Billings Clinic - Downtown, Billings

11794-9446

Stony Brook University Cancer Center, Stony Brook

44309-2090

Summa Center for Cancer Care at Akron City Hospital, Akron

19107-5541

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

NRG Oncology

OTHER

lead

Radiation Therapy Oncology Group

NETWORK

NCT00551525 - Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer | Biotech Hunter | Biotech Hunter